These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 31576015)

  • 1. ΔNp63α exerts antitumor functions in cervical squamous cell carcinoma.
    Zhou Y; Liu H; Wang J; Wang X; Qian L; Xu F; Song W; Wu D; Shen Z; Feng D; Ling B; Xiao W; Shan G; Chen L
    Oncogene; 2020 Jan; 39(4):905-921. PubMed ID: 31576015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
    Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z
    Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development.
    Yi M; Tan Y; Wang L; Cai J; Li X; Zeng Z; Xiong W; Li G; Li X; Tan P; Xiang B
    Cell Mol Life Sci; 2020 Nov; 77(21):4325-4346. PubMed ID: 32447427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3.
    Zhao A; Pan Y; Gao Y; Zhi Z; Lu H; Dong B; Zhang X; Wu M; Zhu F; Zhou S; Ma S
    BMC Cancer; 2024 May; 24(1):559. PubMed ID: 38702644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of ΔNp63α by miR-522 promotes the migration of breast epithelial cells.
    Dong Y; Long J; Luo X; Xie G; Xiao ZJ; Tong Y
    FEBS Open Bio; 2021 Feb; 11(2):468-481. PubMed ID: 33369228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of GLIS1 on the Lymph Node Metastasis of Cervical Squamous Carcinoma Based on Transcriptome Analysis.
    Huang J; Zhao Y
    Reprod Sci; 2024 May; 31(5):1332-1344. PubMed ID: 38157104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ΔNp63α regulates Erk signaling via MKP3 to inhibit cancer metastasis.
    Bergholz J; Zhang Y; Wu J; Meng L; Walsh EM; Rai A; Sherman MY; Xiao ZX
    Oncogene; 2014 Jan; 33(2):212-24. PubMed ID: 23246965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ΔNp63α in cancer: importance and therapeutic opportunities.
    Fisher ML; Balinth S; Mills AA
    Trends Cell Biol; 2023 Apr; 33(4):280-292. PubMed ID: 36115734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated TP63 induces transcription of RPN13, leading to NOS2 protein degradation.
    Huang Y; Ratovitski EA
    J Biol Chem; 2010 Dec; 285(53):41422-31. PubMed ID: 20959455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of mecciRNAs and their roles in the mitochondrial entry of proteins.
    Liu X; Wang X; Li J; Hu S; Deng Y; Yin H; Bao X; Zhang QC; Wang G; Wang B; Shi Q; Shan G
    Sci China Life Sci; 2020 Oct; 63(10):1429-1449. PubMed ID: 32048164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation.
    Kombe Kombe AJ; Li B; Zahid A; Mengist HM; Bounda GA; Zhou Y; Jin T
    Front Public Health; 2020; 8():552028. PubMed ID: 33553082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP63-TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer.
    Sultanov R; Mulyukina A; Zubkova O; Fedoseeva A; Bogomazova A; Klimina K; Larin A; Zatsepin T; Prikazchikova T; Lukina M; Bogomiakova M; Sharova E; Generozov E; Lagarkova M; Arapidi G
    Epigenetics Chromatin; 2024 Mar; 17(1):6. PubMed ID: 38481282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ∆Np63α inhibits Rac1 activation and cancer cell invasion through suppression of PREX1.
    Aljagthmi AA; Hira A; Zhang J; Cooke M; Kazanietz MG; Kadakia MP
    Cell Death Discov; 2024 Jan; 10(1):13. PubMed ID: 38191532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer.
    Mourtada J; Lony C; Nicol A; De Azevedo J; Bour C; Macabre C; Roncarati P; Ledrappier S; Schultz P; Borel C; Burgy M; Wasylyk B; Mellitzer G; Herfs M; Gaiddon C; Jung AC
    Front Immunol; 2023; 14():1264093. PubMed ID: 38022675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications.
    Li Y; Gao X; Huang Y; Zhu X; Chen Y; Xue L; Zhu Q; Wang B; Wu M
    Front Oncol; 2023; 13():1114042. PubMed ID: 37234990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA ARHGAP5 inhibits cisplatin resistance in cervical squamous cell carcinoma by interacting with AUF1.
    Deng S; Qian L; Liu L; Liu H; Xu Z; Liu Y; Wang Y; Chen L; Zhou Y
    Cancer Sci; 2023 Apr; 114(4):1582-1595. PubMed ID: 36632741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia.
    Laidou S; Grigoriadis D; Papanikolaou S; Foutadakis S; Ntoufa S; Tsagiopoulou M; Vatsellas G; Anagnostopoulos A; Kouvatsi A; Stavroyianni N; Psomopoulos F; Makris AM; Agelopoulos M; Thanos D; Chatzidimitriou A; Papakonstantinou N; Stamatopoulos K
    Blood Adv; 2022 Apr; 6(8):2646-2656. PubMed ID: 35235952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SYT7 acts as an oncogene and a potential therapeutic target and was regulated by ΔNp63α in HNSCC.
    Fu Y; Tian G; Zhang Z; Yang X
    Cancer Cell Int; 2021 Dec; 21(1):696. PubMed ID: 34930262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma.
    Liu H; Zhu C; Xu Z; Wang J; Qian L; Zhou Q; Shen Z; Zhao W; Xiao W; Chen L; Zhou Y
    Cancer Sci; 2020 Nov; 111(11):4129-4141. PubMed ID: 32920922
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.